OncoTherics CEO, Stefan Ogrodzinski, was one of fifty life science and med tech companies to be selected to pitch at this years Texas Life Science …
Read more
Multi-omics analysis reveals panoramic picture of TOP2A in pan cancer
A new paper by Zhang et al. (Scientific Reports, 2025) provides the most comprehensive multi-omics analysis to date of TOP2A, revealing that this key nuclear …
Read more
OncoTherics to pitch at the 14th Annual Texas Life Science Forum
The Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance, is the premier life science and healthtech event in Texas that brings together members …
Read more
OncoTherics visits MSKCC and MDAnderson to advance translational programme
OncoTherics’ U.S. clinical translational strategy was advanced this week through discussions with key colleagues at Memorial Sloane Kettering Cancer Centre (New York) and MD Anderson …
Read more
Elucidating the Prognostic and Therapeutic significance of TOP2A in various malignancies
A recent paper by Liu et al. (Cancer Genetics, 2024), titled “Elucidating the Prognostic and Therapeutic Significance of TOP2A in Various Malignancies,” reinforces the central …
Read more
OncoTherics completes first part of DMPK equivalence programme
OncoTherics has successfully completed a sophisticated cross-species in vitro metabolism study designed to evaluate any difference between OCT1004 and its next generation isotopolog OCT1002 in …
Read more
Glioma Organization Untangled Using Spatial Transcriptomic, Proteomic Profiles
A landmark study by Wang et al. (Nature, 2024), titled “Integrative Spatial Analysis Reveals a Multi-layered Organization of Glioblastoma,” has transformed our understanding of one …
Read more
OncoTherics seeks SMART funding to support DMPK programme
After taking expert advice from world class toxicology and DMPK experts, OncoTherics has commenced an innovative DMPK equivalence programme. The close chemical relationship between OCT1002 …
Read more
OncoTherics completes CMC scale up development
GMP scale up development has been completed for OCT1002 and OCT1004. The synthesis route has been re-designed for both assets to ensure ready supply of …
Read more
OncoTherics Poland SA AGM 2023
OncoTherics second annual general meeting was held on 30th June 2023 and the FY2022 audited accounts were approved. The company looks forward to progressing its …
Read more